Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s…